Mitochondrial dysfunction and cellular metabolic deficiency in Alzheimer's disease

Neuroscience Bulletin

Volumn 28, Issue 5, 2012, Pages 631-640

  Gu, Xue Mei ^a   Huang, Han Chang ^b,c   Jiang, Zhao Feng ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b BEIJING UNION UNIVERSITY   (China)

^c BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY   (China)

Author keywords

Alzheimer's disease; Amyloid ; Metabolic deficiency; Mitochondrial dysfunction

Indexed keywords

ALCOHOL DEHYDROGENASE; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CELL SURFACE PROTEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; LACTIC ACID; NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE;

ALZHEIMER DISEASE; APOPTOSIS; BIOACCUMULATION; BIOGENESIS; BRAIN METABOLISM; CELL METABOLISM; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DAMAGE; ENERGY METABOLISM; HOMEOSTASIS; HUMAN; LIPID PEROXIDATION; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; ANIMALS; GLUCOSE; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MITOCHONDRIA;

EID: 84871452231     PISSN: 16737067     EISSN: 19958218     Source Type: Journal    
DOI: 10.1007/s12264-012-1270-2     Document Type: Review

References (83)

1. Huang HC, Jiang ZF. Amyloid-beta protein precursor family members: a review from homology to biological function. J Alzheimers Dis 2011, 26: 607-626.
2. Huang HC, Jiang ZF. Accumulated amyloid-beta peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer's disease. J Alzheimers Dis 2009, 16: 15-27.
3. Kapogiannis D, Mattson MP. Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease. Lancet Neurol 2011, 10: 187-198.
4. Sultana R, Mecocci P, Mangialasche F, Cecchetti R, Baglioni M, Butterfield DA. Increased protein and lipid oxidative damage in mitochondria isolated from lymphocytes from patients with Alzheimer's disease: insights into the role of oxidative stress in Alzheimer's disease and initial investigations into a potential biomarker for this dementing disorder. J Alzheimers Dis 2011, 24: 77-84.
5. Ishii K, Sasaki M, Kitagaki H, Yamaji S, Sakamoto S, Matsuda K, et al. Reduction of cerebellar glucose metabolism in advanced Alzheimer's disease. J Nucl Med 1997, 38: 925-928. (Pubitemid 27251986)
6. Kennedy AM, Frackowiak RS, Newman SK, Bloomfield PM, Seaward J, Roques P, et al. Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease. Neurosci Lett 1995, 186: 17-20.
7. Furst AJ, Lal RA. Amyloid-beta and glucose metabolism in Alzheimer's disease. J Alzheimers Dis 2011, 26 (Suppl 3): 105-116.
8. Hoyer S. Glucose metabolism and insulin receptor signal transduction in Alzheimer disease. Eur J Pharmacol 2004, 490: 115-125. (Pubitemid 38482165)
9. Young-Collier KJ, McArdle M, Bennett JP. The dying of the light: mitochondrial failure in Alzheimer's disease. J Alzheimers Dis 2012, 28: 771-781.
10. Liang WS, Reiman EM, Valla J, Dunckley T, Beach TG, Grover A, et al. Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons. Proc Natl Acad Sci U S A 2008, 105: 4441-4446. (Pubitemid 351754399)
11. Selfridge JE, Lu J, Swerdlow RH. Role of mitochondrial homeostasis and dynamics in Alzheimer's disease. Neurobiol Dis 2012, doi:10.1016/j.nbd.2011.12. 057.
12. Sheng B, Wang X, Su B, Lee HG, Casadesus G, Perry G, et al. Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease. J Neurochem 2012, 120: 419-429.
13. Carey RM, Balcz BA, Lopez-Coviella I, Slack BE. Inhibition of dynamin-dependent endocytosis increases shedding of the amyloid precursor protein ectodomain and reduces generation of amyloid beta protein. BMC Cell Biol 2005, 6: 30.
14. Koo EH, Squazzo SL, Selkoe DJ, Koo CH. Trafficking of cellsurface amyloid beta-protein precursor. I. Secretion, endocytosis and recycling as detected by labeled monoclonal antibody. J Cell Sci 1996, 109 (Pt 5): 991-998.
15. Yamazaki T, Koo EH, Selkoe DJ. Trafficking of cell-surface amyloid beta-protein precursor. II. Endocytosis, recycling and lysosomal targeting detected by immunolocalization. J Cell Sci 1996, 109 (Pt 5): 999-1008. (Pubitemid 126477168)
16. Pasternak SH, Bagshaw RD, Guiral M, Zhang S, Ackerley CA, Pak BJ, et al. Presenilin-1, nicastrin, amyloid precursor protein, and gamma-secretase activity are co-localized in the lysosomal membrane. J Biol Chem 2003, 278: 26687-26694. (Pubitemid 36876814)
17. Zhang YW, Thompson R, Zhang H, Xu H. APP processing in Alzheimer's disease. Mol Brain 2011, 4: 3.
18. Greenfield JP, Tsai J, Gouras GK, Hai B, Thinakaran G, Checler F, et al. Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer beta-amyloid peptides. Proc Natl Acad Sci U S A 1999, 96: 742-747. (Pubitemid 29061279)
19. Annaert WG, Levesque L, Craessaerts K, Dierinck I, Snellings G, Westaway D, et al. Presenilin 1 controls gamma-secretase processing of amyloid precursor protein in pre-golgi compartments of hippocampal neurons. J Cell Biol 1999, 147: 277-294. (Pubitemid 29496338)
20. Verdier Y, Zarandi M, Penke B. Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease. J Pept Sci 2004, 10: 229-248. (Pubitemid 38594184)
21. Caltagarone J, Jing Z, Bowser R. Focal adhesions regulate Abeta signaling and cell death in Alzheimer's disease. Biochim Biophys Acta 2007, 1772: 438-445. (Pubitemid 46400386)
22. Gouras GK, Tsai J, Naslund J, Vincent B, Edgar M, Checler F, et al. Intraneuronal Abeta42 accumulation in human brain. Am J Pathol 2000, 156: 15-20. (Pubitemid 30644433)
23. Kaminski Schierle GS, van de Linde S, Erdelyi M, Esbjorner EK, Klein T, Rees E, et al. In situ measurements of the formation and morphology of intracellular beta-amyloid fibrils by super-resolution fluorescence imaging. J Am Chem Soc 2011, 133: 12902-12905.
24. Gyure KA, Durham R, Stewart WF, Smialek JE, Troncoso JC. Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome. Arch Pathol Lab Med 2001, 125: 489-492. (Pubitemid 32291552)
25. Knobloch M, Konietzko U, Krebs DC, Nitsch RM. Intracellular Abeta and cognitive deficits precede beta-amyloid deposition in transgenic arcAbeta mice. Neurobiol Aging 2007, 28: 1297-1306. (Pubitemid 47081235)
26. Mohamed A, Posse de Chaves E. Abeta internalization by neurons and glia. Int J Alzheimers Dis 2011, 2011: 127984.
27. Tampellini D, Rahman N, Lin MT, Capetillo-Zarate E, Gouras GK. Impaired beta-amyloid secretion in Alzheimer's disease pathogenesis. J Neurosci 2011, 31: 15384-15390.
28. Tampellini D, Rahman N, Gallo EF, Huang Z, Dumont M, Capetillo- Zarate E, et al. Synaptic activity reduces intraneuronal Abeta, promotes APP transport to synapses, and protects against Abeta-related synaptic alterations. J Neurosci 2009, 29: 9704-9713.
29. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003, 39: 409-421. (Pubitemid 36937044)
30. Bayer TA, Wirths O. Intracellular accumulation of amyloid-Betaa predictor for synaptic dysfunction and neuron loss in Alzheimer's disease. Front Aging Neurosci 2010, 2: 8.
31. Langui D, Girardot N, El Hachimi KH, Allinquant B, Blanchard V, Pradier L, et al. Subcellular topography of neuronal Abeta peptide in APPxPS1 transgenic mice. Am J Pathol 2004, 165: 1465-1477. (Pubitemid 39435147)
32. Borger E, Aitken L, Muirhead KE, Allen ZE, Ainge JA, Conway SJ, et al. Mitochondrial beta-amyloid in Alzheimer's disease. Biochem Soc Trans 2011, 39: 868-873.
33. Reddy PH, Beal MF. Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease. Trends Mol Med 2008, 14: 45-53.
34. Yan SD, Fu J, Soto C, Chen X, Zhu H, Al-Mohanna F, et al. An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in Alzheimer's disease. Nature 1997, 389: 689-695. (Pubitemid 27458947)
35. Oppermann UC, Salim S, Tjernberg LO, Terenius L, Jornvall H. Binding of amyloid beta-peptide to mitochondrial hydroxyacyl- CoA dehydrogenase (ERAB): regulation of an SDR enzyme activity with implications for apoptosis in Alzheimer's disease. FEBS Lett 1999, 451: 238-242. (Pubitemid 29243784)
36. Yan SD, Stern DM. Mitochondrial dysfunction and Alzheimer's disease: role of amyloid-beta peptide alcohol dehydrogenase (ABAD). Int J Exp Pathol 2005, 86: 161-171. (Pubitemid 40813912)
37. Lustbader JW, Cirilli M, Lin C, Xu HW, Takuma K, Wang N, et al. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 2004, 304: 448-452. (Pubitemid 38495942)
38. Yao J, Du H, Yan S, Fang F, Wang C, Lue LF, et al. Inhibition of amyloid-beta (Abeta) peptide-binding alcohol dehydrogenase- Abeta interaction reduces Abeta accumulation and improves mitochondrial function in a mouse model of Alzheimer's disease. J Neurosci 2011, 31: 2313-2320.
39. Lee HP, Pancholi N, Esposito L, Previll LA, Wang X, Zhu X, et al. Early induction of oxidative stress in mouse model of Alzheimer disease with reduced mitochondrial superoxide dismutase activity. PLoS One 2012, 7: e28033.
40. Mao P, Reddy PH. Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer's disease: implications for early intervention and therapeutics. Biochim Biophys Acta 2011, 1812: 1359-1370.
41. Butterfield DA, Bader Lange ML, Sultana R. Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease. Biochim Biophys Acta 2010, 1801: 924-929.
42. Grimm S, Hoehn A, Davies KJ, Grune T. Protein oxidative modifications in the ageing brain: consequence for the onset of neurodegenerative disease. Free Radic Res 2011, 45: 73-88.
43. Srikanth V, Maczurek A, Phan T, Steele M, Westcott B, Juskiw D, et al. Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease. Neurobiol Aging 2011, 32: 763-777.
44. Williams TI, Lynn BC, Markesbery WR, Lovell MA. Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease. Neurobiol Aging 2006, 27: 1094-1099. (Pubitemid 43850642)
45. Bradley MA, Markesbery WR, Lovell MA. Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease. Free Radic Biol Med 2010, 48: 1570-1576.
46. McGarth LT, McGleenon BM, Brennan S, McColl D, McIlroy S, Passmore AP. Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde. QJM 2001, 94: 485-490. (Pubitemid 32894467)
47. Nam DT, Arseneault M, Murthy V, Ramassamy C. Potential role of acrolein in neurodegeneration and in Alzheimer's disease. Curr Mol Pharmacol 2010, 3: 66-78.
48. Perluigi M, Sultana R, Cenini G, Di Domenico F, Memo M, Pierce WM, et al. Redox proteomics identification of 4-hydroxynonenalmodified brain proteins in Alzheimer's disease: Role of lipid peroxidation in Alzheimer's disease pathogenesis. Proteomics Clin Appl 2009, 3: 682-693.
49. Mark RJ, Pang Z, Geddes JW, Uchida K, Mattson MP. Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. J Neurosci 1997, 17: 1046-1054. (Pubitemid 27043963)
50. Gwon AR, Park JS, Arumugam TV, Kwon YK, Chan SL, Kim SH, et al. Oxidative lipid modification of nicastrin enhances amyloidogenic gamma-secretase activity in Alzheimer's disease. Aging Cell 2012, doi: 10.1111/j.1474-9726.2012.00817.x.
51. Pocernich CB, Butterfield DA. Acrolein inhibits NADH-linked mitochondrial enzyme activity: implications for Alzheimer's disease. Neurotox Res 2003, 5: 515-520.
52. Lovell MA, Markesbery WR. Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease. Nucleic Acids Res 2007, 35: 7497-7504.
53. Jacobsen E, Beach T, Shen Y, Li R, Chang Y. Deficiency of the Mre11 DNA repair complex in Alzheimer's disease brains. Brain Res Mol Brain Res 2004, 128: 1-7. (Pubitemid 39158875)
54. Wang J, Xiong S, Xie C, Markesbery WR, Lovell MA. Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease. J Neurochem 2005, 93: 953-962. (Pubitemid 40695754)
55. Baloyannis SJ. Mitochondria are related to synaptic pathology in Alzheimer's disease. Int J Alzheimers Dis 2011, 2011: 305395.
56. de la Monte SM, Luong T, Neely TR, Robinson D, Wands Jr. Mitochondrial DNA damage as a mechanism of cell loss in Alzheimer's disease. Lab Invest 2000, 80: 1323-1335. (Pubitemid 30637072)
57. Mayer B, Oberbauer R. Mitochondrial regulation of apoptosis. News Physiol Sci 2003, 18: 89-94. (Pubitemid 36782796)
58. Karbowski M. Mitochondria on guard: role of mitochondrial fusion and fission in the regulation of apoptosis. Adv Exp Med Biol 2010, 687: 131-142.
59. Soriano ME, Scorrano L. The interplay between BCL-2 family proteins and mitochondrial morphology in the regulation of apoptosis. Adv Exp Med Biol 2010, 687: 97-114.
60. Kasanuki K, Iseki E, Fujishiro H, Yamamoto R, Higashi S, Minegishi M, et al. Neuropathological investigation of the hypometabolic regions on positron emission tomography with
61. fluorodeoxyglucose in patients with dementia with Lewy bodies. J Neurol Sci 2012, 314: 111-119.
62. Salek RM, Xia J, Innes A, Sweatman BC, Adalbert R, Randle S, et al. A metabolomic study of the CRND8 transgenic mouse model of Alzheimer's disease. Neurochem Int 2010, 56: 937-947.
63. Yates CM, Butterworth J, Tennant MC, Gordon A. Enzyme activities in relation to pH and lactate in postmortem brain in Alzheimertype and other dementias. J Neurochem 1990, 55: 1624-1630.
64. Xiang Y, Xu G, Weigel-Van Aken KA. Lactic acid induces aberrant amyloid precursor protein processing by promoting its interaction with endoplasmic reticulum chaperone proteins. PLoS One 2010, 5: e13820.
65. Stubbs M, Veech RL, Krebs HA. Control of the redox state of the nicotinamide-adenine dinucleotide couple in rat liver cytoplasm. Biochem J 1972, 126: 59-65.
66. Zhang Q, Piston DW, Goodman RH. Regulation of corepressor function by nuclear NADH. Science 2002, 295: 1895-1897. (Pubitemid 34214127)
67. McKenna MC, Waagepetersen HS, Schousboe A, Sonnewald U. Neuronal and astrocytic shuttle mechanisms for cytosolic-mitochondrial transfer of reducing equivalents: current evidence and pharmacological tools. Biochem Pharmacol 2006, 71: 399-407. (Pubitemid 43077074)
68. Huang HC, Xu K, Jiang ZF. Curcumin-mediated neuroprotection against amyloid-beta-induced mitochondrial dysfunction involves the inhibition of GSK-3beta. J Alzheimers Dis 2012, doi: 10.3233/ JAD-2012-120688.
69. Yang Y, Turner RS, Gaut Jr. The chaperone BiP/GRP78 binds to amyloid precursor protein and decreases Abeta40 and Abeta42 secretion. J Biol Chem 1998, 273: 25552-25555. (Pubitemid 28475772)
70. Kudo T, Okumura M, Imaizumi K, Araki W, Morihara T, Tanimukai H, et al. Altered localization of amyloid precursor protein under endoplasmic reticulum stress. Biochem Biophys Res Commun 2006, 344: 525-530.
71. Sirover MA. New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase. Biochim Biophys Acta 1999, 1432: 159-184. (Pubitemid 29304525)
72. Harada N, Yasunaga R, Higashimura Y, Yamaji R, Fujimoto K, Moss J, et al. Glyceraldehyde-3-phosphate dehydrogenase enhances transcriptional activity of androgen receptor in prostate cancer cells. J Biol Chem 2007, 282: 22651-22661. (Pubitemid 47267369)
73. Tarze A, Deniaud A, Le Bras M, Maillier E, Molle D, Larochette N, et al. GAPDH, a novel regulator of the pro-apoptotic mitochondrial membrane permeabilization. Oncogene 2007, 26: 2606-2620. (Pubitemid 46632015)
74. Tisdale EJ. Glyceraldehyde-3-phosphate dehydrogenase is required for vesicular transport in the early secretory pathway. J Biol Chem 2001, 276: 2480-2486.
75. Butterfield DA, Hardas SS, Lange ML. Oxidatively modified glyceraldehyde- 3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease: many pathways to neurodegeneration. J Alzheimers Dis 2010, 20: 369-393.
76. Shalova IN, Cechalova K, Rehakova Z, Dimitrova P, Ognibene E, Caprioli A, et al. Decrease of dehydrogenase activity of cerebral glyceraldehyde-3- phosphate dehydrogenase in different animal models of Alzheimer's disease. Biochim Biophys Acta 2007, 1770: 826-832. (Pubitemid 46420628)
77. Cumming RC, Schubert D. Amyloid-beta induces disulfide bonding and aggregation of GAPDH in Alzheimer's disease. FASEB J 2005, 19: 2060-2062. (Pubitemid 41759765)
78. Wang Q, Woltjer RL, Cimino PJ, Pan C, Montine KS, Zhang J, et al. Proteomic analysis of neurofibrillary tangles in Alzheimer disease identifies GAPDH as a detergent-insoluble paired helical filament tau binding protein. FASEB J 2005, 19: 869-871. (Pubitemid 40617412)
79. Schulze H, Schuler A, Stuber D, Dobeli H, Langen H, Huber G. Rat brain glyceraldehyde-3-phosphate dehydrogenase interacts with the recombinant cytoplasmic domain of Alzheimer's beta-amyloid precursor protein. J Neurochem 1993, 60: 1915-1922. (Pubitemid 23127600)
80. Naletova I, Schmalhausen E, Kharitonov A, Katrukha A, Saso L, Caprioli A, et al. Non-native glyceraldehyde-3-phosphate dehydrogenase can be an intrinsic component of amyloid structures. Biochim Biophys Acta 2008, 1784: 2052-2058.
81. Parker WD Jr, Parks J, Filley CM, Kleinschmidt-DeMasters BK. Electron transport chain defects in Alzheimer's disease brain. Neurology 1994, 44: 1090-1096. (Pubitemid 24188184)
82. Fukuyama R, Hatanpaa K, Rapoport SI, Chandrasekaran K. Gene expression of ND4, a subunit of complex I of oxidative phosphorylation in mitochondria, is decreased in temporal cortex of brains of Alzheimer's disease patients. Brain Res 1996, 713: 290-293. (Pubitemid 26114850)
83. Manczak M, Park BS, Jung Y, Reddy PH. Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage. Neuromolecular Med 2004, 5: 147-162. (Pubitemid 38596548)